Golden Leaf Holdings issued an update to shareholder on its Canadian subsidiary Medical Marijuana Group.
Golden Leaf Holdings (CSE:GLH) issued an update to shareholder on its Canadian subsidiary Medical Marijuana Group (MMG).
As quoted in the press release:
Sales strategy update
After the extensive testing demonstrated positive test results last week, MMG requested the final sales license inspection required under Health Canada. The request is currently pending. Upon receipt of the sales license, MMG will have considerable product ready for immediate sale, thus completing the build out of the sales cycle. Historically, licenses have taken anywhere from two weeks to two months to receive approval, and the Company has sought as expeditious a process as possible.
William Simpson, Golden Leaf Holdings’ CEO, commented, “We are pleased that MMG has added strength and value to Golden Leaf Holdings’ Canadian expansion strategy. We are confident in our ability to establish MMG as a provider of high quality cannabis oils and edibles to the Canadian market and are pleased with our progress as Canada approaches adult-use legalization on October 17.”